Navigation Links
CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program
Date:6/29/2009

VANCOUVER, June 29 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today that the University of South Alabama College of Medicine in Mobile Alabama has completed a training program involving its Teaching Faculty and Gastroenterology Fellows on the non surgical removal of hemorrhoids using the CRH O'Regan Banding Technology. Commenting on the incorporation of this training program into its Fellowship Program, University of South Alabama Professor of Medicine, Dr. Jack Di Palma said "This program enhances our training curriculum and enhances our Fellowship education program. I would encourage other Fellowship Programs to take advantage of it. Our Fellows enjoyed the training, and will continue to put these skills to good use as their careers progress." Dr Di Palma further stated "Hemorrhoids used to be a nuisance; we now have a proven treatment modality that benefits our patients as well as our practices."

There are currently 162 Fellowship Programs operating in the US. CRH is making this same educational program available to each of these Fellowship Programs. The Company believes that a partnership between itself and gastroenterologists allow for an outstanding continuum of care for patients.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner
'/>"/>

SOURCE CRH Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Surgeons Use USGI Medicals Incisionless Operating Platform to Reduce Pouch, Stoma Size in Gastric Bypass Patients
2. Midbrook Partners with Supply Core Middle East to Provide Water Bottling and Medical Decontamination Equipment to the Middle East and North Africa
3. Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medical Advisors
4. GP bodies support guidelines for use of patient records in medical research
5. Michael Jackson Get the Medical Facts Behind the Headlines at CelebrityDiagnosis.com
6. Ohio Congressional Members Urge U.S. to Provide GM Retirees Medical Benefits
7. The Breast Center at Houston Northwest Medical Center Receives Prestigious National Award
8. Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees
9. Healthcare Staffing Company Medical Solutions Named Among "2009 Best Places to Work in Omaha"
10. Neuropathy Patients, Doctors and Medical Professionals Rally in Sacramento to Demand Access to Lifesaving Medical Treatments
11. Leading Coalitions on Medical Liability Reform Join Forces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013 For more than forty years, ... battle against drug and alcohol abuse around the world. ... first guide to help Italian speakers reverse growing trends ... European Monitoring Centre for Drugs and Drug Addiction show ... cannabis in the last year. As a glimpse of ...
(Date:5/20/2013)... child whose mother lived near heavy traffic while pregnant ... infection before the age of 3, a new study ... pairs of mothers and infants from eastern Massachusetts. All ... trimester of pregnancy at some point between 1999 and ... within 100 meters (about 110 yards) from a major ...
(Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious and ... But with appropriate treatment, there,s an excellent chance of ... reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , The results ...
(Date:5/20/2013)... As high schoolers prepare for final exams, teens ... -- a prescription stimulant or amphetamine -- to gain ... poll shows only one in 100 parents of teens ... a study drug., Study drugs refer to stimulant medications ... disorder (ADHD); commonly prescribed medicines in this category include ...
(Date:5/20/2013)... three out of four pregnant women experience constipation, diarrhea ... University Medical Center study has found. , But such ... quality of life, the study found. , The study ... was presented during the American Congress of Obstetricians and ... One hundred and four pregnant women were enrolled and ...
Breaking Medicine News(10 mins):Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:72 percent of pregnant women experience constipation and other bowel problems 2
... has confirmed the presence of H5N1 bird flu strain in ... of the deadly bird flu strain // in six villages ... ,Early this month five new cases of bird ... flu was first detected in Danube delta in Romania this ...
... has been passed in United Kingdom which allows prescription ... 12 and pregnant women as the risk associated with ... nicotine patches as earlier the sale of nicotine patches ... women and people with chronic diseases such as heart, ...
... The first Chinese outbreak of H5N1 bird flu infection occurred ... thursday the Chinese officials have confirmed // the seventh death ... Zhou was a 41 year old women factory worker of ... and pneumonia, who had an initial H5N1 virus test negative. ...
... from injury tissue by increasing the number of circulating ... ,The report, to be published in the April ... Physiology, says a typical course of hyperbaric oxygen treatments ... patient`s body by eight-fold. ,Stem cells, also ...
... has indicated that China might be using "substandard poultry vaccine", ... deadly outbreaks of bird flu //in that country. ... Memphis, Tennessee, however said that this problem was not confined ... blame China for substandard vaccines. I think there are substandard ...
... As a coin has two sides so does vitamin D, it ... and liver. If taken in high doses vitamin D can be ... based on intakes from 63 studies. , ,The study was ... Garland looked at the relationship between blood levels of Vitamin D ...
Cached Medicine News:
(Date:5/20/2013)... CHICAGO, Ill. , May 20, 2013 /PRNewswire/ ... the initiation of a Phase 3 clinical study ... to assess the effects of the investigational compound ... progression of kidney disease in patients with stage ... type 2 diabetes.  SONAR is a large, multinational, ...
(Date:5/19/2013)...  The non-surgical Stretta® procedure employing ... is effective in control of gastroesophageal reflux disease ... medication 10 years post-procedure, according to an independent, ... Disease Week (DDW) meeting May 18-21, 2013 in ... "The sustained improvement in GERD-HRQL scores and ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Double-Blind Study Targets Biomarker-Defined Population, BERKELEY ... GNTA ) announced that the first ... Phase 3 trial of Genasense,(oblimersen sodium) Injection ... is a randomized, double-blind, placebo-controlled study in ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: